Our flagship stabilization solutions — TheraPHIX™, vivoPHIX™, genoPHIX™, virusPHIX™ and virusPHIX-P9™ — are designed for a wide range of applications within life sciences and therapeutics. vivoPHIX™ leverages advanced molecular stabilization technology to ensure sample integrity during tissue fixation, dissociation, and single-cell workflows, including scRNA-seq and CITE-seq. virusPHIX™ facilitates virus inactivation and secure transport, preserving molecular fidelity for improved diagnostic accuracy and high-quality data generation.
For mRNA-LNP vaccine and therapeutic thermostabilization TheraPHIX™ improves stability and potency in the form an ambient stable injectable liquid formulation.
Company Details
- Employees
- 3
- Founded
- 2012
- Address
- Cambridge, Gb
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://rnassist.com
- Keywords
- RNA and LNP vaccine stabilisation, thermostabilisation, mRNA vaccine and therapeutics, cell stabilisation, scRNA-seq multiomics, biomolecule stabilisation, tissue fixation, protein stabilisation, microbial viability, LNP potency and biodistribution.
- HQ
- Cambridge
Rnassist Questions
Rnassist's website is http://rnassist.com
Rnassist's LinkedIn profile is https://uk.linkedin.com/company/rnassist
Rnassist has
3 employees.
View email and phone details for 3
employees at Rnassist.
Rnassist's industry is
Biotechnology Research
Rnassist's categories are Biotechnology Research
Rnassist's founding year is 2012
